Clinton E. Hagen

2.8k total citations · 1 hit paper
42 papers, 2.0k citations indexed

About

Clinton E. Hagen is a scholar working on Psychiatry and Mental health, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Clinton E. Hagen has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 12 papers in Physiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Clinton E. Hagen's work include Dementia and Cognitive Impairment Research (18 papers), Alzheimer's disease research and treatments (8 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Clinton E. Hagen is often cited by papers focused on Dementia and Cognitive Impairment Research (18 papers), Alzheimer's disease research and treatments (8 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Clinton E. Hagen collaborates with scholars based in United States, Netherlands and Puerto Rico. Clinton E. Hagen's co-authors include Michelle M. Mielke, Ronald C. Petersen, David S. Knopman, Rosebud O. Roberts, Mary M. Machulda, Clifford R. Jack, Alexandra Wennberg, Jeffrey L. Dage, David Airey and Prashanthi Vemuri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Clinton E. Hagen

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

2018 413 citations Michelle M. Mielke, Clinton E. Hagen et al. Alzheimer s & Dementia profile →

Peers

Countries citing papers authored by Clinton E. Hagen

Since Specialization

Citations

This map shows the geographic impact of Clinton E. Hagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinton E. Hagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinton E. Hagen more than expected).

Fields of papers citing papers by Clinton E. Hagen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clinton E. Hagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clinton E. Hagen. The network helps show where Clinton E. Hagen may publish in the future.

Co-authorship network of co-authors of Clinton E. Hagen

This figure shows the co-authorship network connecting the top 25 collaborators of Clinton E. Hagen. A scholar is included among the top collaborators of Clinton E. Hagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clinton E. Hagen. Clinton E. Hagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections 2025 ·Stem Cell Research & Therapy ·(unknown), James Jaggers, Harold M. Burkhart, Waldemar F. Carlo, David L.S. Morales, M. Yasir Qureshi, Joseph W. Rossano, Clinton E. Hagen, Drew K. Seisler, (unknown), Timothy J. Nelson	0
2	Study Design Considerations for Generating Real-world Evidence With Digital Biomarkers in Older Adult Populations: Lessons Learned From a Pilot Smartphone Study 2024 ·SSRN Electronic Journal ·(unknown), (unknown), Clinton E. Hagen, Bart M. Demaerschalk, Bradley J. Erickson	1
3	Optimizing RNA extraction methods for high-throughput transcriptome sequencing of formalin-fixed paraffin-embedded cardiac tissue specimens 2024 ·PLoS ONE ·Nkechi Martina Odogwu, Jin Sung Jang, Sabrina M. Albertson, Clinton E. Hagen, (unknown), (unknown), Timothy J. Nelson	0
4	Use of a Shear Reduction Surface for Prehospital Transport: A Randomized Crossover Study 2023 ·Advances in Skin & Wound Care ·(unknown), Kathleen S. Berns, Evan Call, (unknown), (unknown), (unknown), Lucas A. Myers, Clinton E. Hagen, Jay Mandrekar, (unknown)	0
5	Transcriptome studies of congenital heart diseases: identifying current gaps and therapeutic frontiers 2023 ·Frontiers in Genetics ·Nkechi Martina Odogwu, Clinton E. Hagen, Timothy J. Nelson	3
6	In-Hospital Versus Out-of-Hospital Stroke Onset Comparison of Process Metrics in a Community Primary Stroke Center 2023 ·SHILAP Revista de lepidopterología ·Felix E. Chukwudelunzu, Bart M. Demaerschalk, (unknown), (unknown), Donn Dexter, (unknown), Clinton E. Hagen	1
7	Limited diagnostic impact of duplications <1 Mb of uncertain clinical significance: a 10-year retrospective analysis of reporting practices at the Mayo Clinic 2020 ·Genetics in Medicine ·Cherisse A. Marcou, Beth A. Pitel, Clinton E. Hagen, Nicole J. Boczek, Ross Rowsey, Linda B. Baughn, Nicole L. Hoppman, Erik C. Thorland, Hutton M. Kearney	4
8	Longitudinal association between phosphatidylcholines, neuroimaging measures of Alzheimer's disease pathophysiology, and cognition in the Mayo Clinic Study of Aging 2019 ·Neurobiology of Aging ·Danni Li, Clinton E. Hagen, (unknown), Hai H. Bui, David S. Knopman, Prashanthi Vemuri, Mary M. Machulda, Clifford R. Jack, Ronald C. Petersen, Michelle M. Mielke	8
9	Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging 2018 ·Experimental Gerontology ·Alexandra Wennberg, Clinton E. Hagen, Ronald C. Petersen, Michelle M. Mielke	16
10	The association between peripheral total IGF-1, IGFBP-3, and IGF-1/IGFBP-3 and functional and cognitive outcomes in the Mayo Clinic Study of Aging 2018 ·Neurobiology of Aging ·Alexandra Wennberg, Clinton E. Hagen, Mary M. Machulda, John H. Hollman, Rosebud O. Roberts, David S. Knopman, Ronald C. Petersen, Michelle M. Mielke	35
11	Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging 2017 ·JAMA Neurology ·Michelle M. Mielke, Clinton E. Hagen, Alexandra Wennberg, David Airey, Rodolfo Savica, David S. Knopman, Mary M. Machulda, Rosebud O. Roberts, Clifford R. Jack, Ronald C. Petersen, Jeffrey L. Dage	149
12	The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample–based analysis 2017 ·American Journal of Obstetrics and Gynecology ·Ariela L. Marshall, Urshila Durani, Adam C. Bartley, Clinton E. Hagen, Aneel A. Ashrani, Carl H. Rose, Ronald S. Go, Rajiv K. Pruthi	84
13	Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study 2017 ·Archives of Gerontology and Geriatrics ·Alexandra Wennberg, Clinton E. Hagen, Rebecca F. Gottesman, Vadim Zipunnikov, Christopher N. Kaufmann, Marilyn Albert, George W. Rebok, Judith D. Kasper, Adam P. Spira	14
14	Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging 2016 ·Journal of Alzheimer s Disease ·Rodolfo Savica, Alexandra Wennberg, Clinton E. Hagen, Kelly K. Edwards, Rosebud O. Roberts, John H. Hollman, David S. Knopman, Bradley F. Boeve, Mary M. Machulda, Ronald C. Petersen, Michelle M. Mielke	80
15	Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population‐based elderly cohort 2016 ·Alzheimer s & Dementia ·Jeffrey L. Dage, Alexandra Wennberg, David Airey, Clinton E. Hagen, David S. Knopman, Mary M. Machulda, Rosebud O. Roberts, Clifford R. Jack, Ronald C. Petersen, Michelle M. Mielke	102
16	Detection of Recurrent Prostate Cancer After Radical Prostatectomy: Comparison of ¹¹C-Choline PET/CT with Pelvic Multiparametric MR Imaging with Endorectal Coil 2014 ·Journal of Nuclear Medicine ·Kazuhiro Kitajima, Robert C. Murphy, Mark A. Nathan, Adam T. Froemming, Clinton E. Hagen, Naoki Takahashi, Akira Kawashima	175
17	Lumbar Transforaminal Epidural Steroid Injections: Does Immediate Post-Procedure Pain Response Predict Longer Term Effectiveness? 2014 ·Pain Medicine ·Christine El-Yahchouchi, John T. Wald, Jeffrey S. Brault, Jennifer R. Geske, Clinton E. Hagen, Naveen S. Murthy, Timothy J. Kaufmann, Kent R. Thielen, Jonathan M. Morris, Felix E. Diehn, Kimberly K. Amrami, Rickey E. Carter, Randy A. Shelerud, Timothy P. Maus	19
18	Impact of Pleural Manometry on the Development of Chest Discomfort During Thoracentesis 2014 ·Journal of Bronchology & Interventional Pulmonology ·Jasleen Pannu, Zachary S. DePew, John J. Mullon, Craig Daniels, Clinton E. Hagen, Fabien Maldonado	19
19	Synthesis and Preliminary Evaluation of N-(16-¹⁸F-Fluorohexadecanoyl)ethanolamine (¹⁸F-FHEA) as a PET Probe of N-Acylethanolamine Metabolism in Mouse Brain 2014 ·ACS Chemical Neuroscience ·Mukesh K. Pandey, Timothy R. DeGrado, Kun Qian, (unknown), Clinton E. Hagen, R. Duclos, S. John Gatley	8
20	Utility of Magnetic Resonance Imaging for Detection of Longitudinal Split Tear of the Ulnotriquetral Ligament 2013 ·The Journal Of Hand Surgery ·Michael D. Ringler, Benjamin M. Howe, Kimberly K. Amrami, Clinton E. Hagen, Richard A. Berger	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact